Alzamend Neuro Presents Preliminary AL001 Brain Connectivity Findings
Alzamend Neuro presented preliminary fMRI findings comparing AL001 with lithium carbonate in six healthy participants. The study showed descriptive differences in brain connectivity, but no changes survived statistical correction. The company noted the small sample size and need for further study. The findings were presented at the Society for Neuroscience annual meeting on November 18, 2026, according to an SEC filing.


